SAB Biotherapeutics (SABS) Enters $20M Equity Sales Agreement

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/17/2026

1. SPY
2. GNK
3. NVDA
4. PLUR
5. AZN
6. SPCX
7. FNGR
8. GSAT
9. S
10. AGPU

Go back to SAB Biotherapeutics (SABS) Enters $20M Equity Sales Agreement
(NASDAQ: SABS) Delayed: 3.81 +0.11 (2.97%)
Previous Close $3.70    52 Week High $ 
Open $3.70    52 Week Low $ 
Day High $3.85    P/E N/A 
Day Low $3.69    EPS $ 
Volume 85,784